{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:53:31Z","timestamp":1781679211274,"version":"3.54.5"},"reference-count":17,"publisher":"Norwegian Medical Association","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2016,11,8]]},"DOI":"10.4045\/tidsskr.16.0207","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T09:05:16Z","timestamp":1478768716000},"page":"1731-4","source":"Crossref","is-referenced-by-count":0,"title":["En kvinne med feber, r\u00f8de \u00f8yne og utbredt utslett"],"prefix":"10.4045","volume":"136","author":[{"given":"\u00d8yvind Magne","family":"Bremnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Grimstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja Eskeland","family":"Bremnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Roujeau JC. Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme. J Dermatol 1997; 24: 726\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9433029&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1346-8138.1997.tb02524.x","DOI":"10.1111\/j.1346-8138.1997.tb02524.x"},{"key":"ref=2","unstructured":"French LE, Prins C. Erythema Multiforme, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. I: Bolognia JL, Jorizzo JL, Schaffer JV et al, red. Dermatology. 3. utg. Amsterdam: Elsevier Saunders, 2012: 323\u2009\u2013\u2009333."},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Kohanim S, Palioura S, Saeed HN et al. Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis \u2013 A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease. Ocul Surf 2016; 14: 168\u2009\u2013\u200988. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26882981&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.jtos.2016.02.001","DOI":"10.1016\/j.jtos.2016.02.001"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Palmieri TL, Greenhalgh DG, Saffle JR et al. A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. J Burn Care Rehabil 2002; 23: 87\u2009\u2013\u200996. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11882797&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097\/00004630-200203000-00004","DOI":"10.1097\/00004630-200203000-00004"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Sekula P, Dunant A, Mockenhaupt M et al. Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Invest Dermatol 2013; 133: 1197\u2009\u2013\u2009204. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23389396&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038\/jid.2012.510","DOI":"10.1038\/jid.2012.510"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Bigby M, Jick S, Jick H et al. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986; 256: 3358\u2009\u2013\u200963. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2946876&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1001\/jama.1986.03380240052027","DOI":"10.1001\/jama.1986.03380240052027"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Manriquez J, Andino-Navarrete R, Cataldo-Cerda K et al. Progression of drug exanthemas to serious drug eruptions: A retrospective review identifying early determinants. Australas J Dermatol 2016; 57: e83\u2009\u2013\u20097. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26012724&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/ajd.12347","DOI":"10.1111\/ajd.12347"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272\u2009\u2013\u200985. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7794310&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056\/NEJM199411103311906","DOI":"10.1056\/NEJM199411103311906"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Kohanim S, Palioura S, Saeed HN et al. Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis \u2013 A Comprehensive Review and Guide to Therapy. I. Systemic Disease. Ocul Surf 2016; 14: 2\u2009\u2013\u200919. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26549248&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.jtos.2015.10.002","DOI":"10.1016\/j.jtos.2015.10.002"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Garcia-Doval I, LeCleach L, Bocquet H et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 2000; 136: 323\u2009\u2013\u20097. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10724193&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1001\/archderm.136.3.323","DOI":"10.1001\/archderm.136.3.323"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Huang YC, Li YC, Chen TJ. The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis. Br J Dermatol 2012; 167: 424\u2009\u2013\u200932. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22458671&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1365-2133.2012.10965.x","DOI":"10.1111\/j.1365-2133.2012.10965.x"},{"key":"ref=12","unstructured":"Mahajan R, Kanwar AJ. Use of granulocyte colony-stimulating factor in the treatment of toxic epidermal necrolysis\u2013experience with 3 patients. Skinmed 2013; 11: 269\u2009\u2013\u200971. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24340465&dopt=Abstract"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Halevy S, Ghislain PD, Mockenhaupt M et al. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 2008; 58: 25\u2009\u2013\u200932. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17919772&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.jaad.2007.08.036","DOI":"10.1016\/j.jaad.2007.08.036"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Stamp LK, Day RO, Yun J. Allopurinol hypersensitivity: investigating the cause and minimizing the risk. Nat Rev Rheumatol 2016; 12: 235\u2009\u2013\u200942. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26416594&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038\/nrrheum.2015.132","DOI":"10.1038\/nrrheum.2015.132"},{"key":"ref=15","unstructured":"R\u00f8devand E, Sletvold O, Kvande KT. Bivirkninger av allopurinol. Tidsskr Nor L\u00e6geforen 2004; 124: 2618\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15534635&dopt=Abstract"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Ramasamy SN, Korb-Wells CS, Kannangara DR et al. Allopurinol hypersensitivity: a systematic review of all published cases, 1950\u2009\u2013\u20092012. Drug Saf 2013; 36: 953\u2009\u2013\u200980. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23873481&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007\/s40264-013-0084-0","DOI":"10.1007\/s40264-013-0084-0"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Mockenhaupt M, Viboud C, Dunant A et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 2008; 128: 35\u2009\u2013\u200944. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17805350&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038\/sj.jid.5701033","DOI":"10.1038\/sj.jid.5701033"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:01:59Z","timestamp":1781676119000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2016\/11\/noe-laere-av\/en-kvinne-med-feber-rode-oyne-og-utbredt-utslett"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,8]]},"references-count":17,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2016,11,8]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.16.0207","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,8]]}}}